Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates

Trastuzumab emtansine and trastuzumab deruxtecan are widely used in breast cancer and other solid tumor malignancies. Thrombocytopenia is a common adverse event associated with the use of these agents that can lead to a treatment delay, reduction in dose intensity, and discontinuation. The role of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rainone, Michael, Kasparian, Saro, Nguyen, Tina, Talwar, Neel, Yuan, Yuan, Mei, Matthew, Mortimer, Joanne E, Waisman, James R, Patel, Niki, Pullarkat, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485295/
https://www.ncbi.nlm.nih.gov/pubmed/37335880
http://dx.doi.org/10.1093/oncolo/oyad185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485295/
https://www.ncbi.nlm.nih.gov/pubmed/37335880
http://dx.doi.org/10.1093/oncolo/oyad185

Ejemplares similares